Considerations on implementation of the newest treatment for symptomatic uterine fibroids : oral GnRH antagonists
| dc.contributor.author | de Lange, Maria E | |
| dc.contributor.author | Semmler, Annika | |
| dc.contributor.author | Clark, T Justin | |
| dc.contributor.author | Mol, Ben Willem J | |
| dc.contributor.author | Bet, Pierre M | |
| dc.contributor.author | Huirne, Judith A F | |
| dc.contributor.author | Hehenkamp, Wouter J K | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-02-14T15:59:01Z | |
| dc.date.available | 2024-02-14T15:59:01Z | |
| dc.date.issued | 2024-02-01 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 14 | |
| dc.format.extent | 729090 | |
| dc.identifier | 281971049 | |
| dc.identifier | 2bb6f502-93fa-4090-b4b5-16bf337af56c | |
| dc.identifier | 37653680 | |
| dc.identifier | 85172098091 | |
| dc.identifier.citation | de Lange, M E, Semmler, A, Clark, T J, Mol, B W J, Bet, P M, Huirne, J A F & Hehenkamp, W J K 2024, 'Considerations on implementation of the newest treatment for symptomatic uterine fibroids : oral GnRH antagonists', British Journal of Clinical Pharmacology, vol. 90, no. 2, pp. 392-404. https://doi.org/10.1111/bcp.15897 | en |
| dc.identifier.doi | 10.1111/bcp.15897 | |
| dc.identifier.iss | 2 | en |
| dc.identifier.issn | 0306-5251 | |
| dc.identifier.uri | https://hdl.handle.net/2164/22760 | |
| dc.identifier.vol | 90 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | British Journal of Clinical Pharmacology | en |
| dc.subject | elagolix | en |
| dc.subject | fibroids | en |
| dc.subject | leiomyoma | en |
| dc.subject | linzagolix | en |
| dc.subject | oral GnRH antagonist | en |
| dc.subject | relugolix | en |
| dc.subject | RG Gynecology and obstetrics | en |
| dc.subject.lcc | RG | en |
| dc.title | Considerations on implementation of the newest treatment for symptomatic uterine fibroids : oral GnRH antagonists | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- DeLange_etal_BJCP_Considerations_On_Implementation_VoR.pdf
- Size:
- 712 KB
- Format:
- Adobe Portable Document Format
